Exergames für Patienten mit komplexem regionalem Schmerzsyndrom

Storz, Claudia; Schulte-Göcking, Heike; Woiczinski, Matthias; Azqueta‐Gavaldon, Monica; Azad, Shahnaz Christina; Kraft, Eduard

doi:10.1007/s00482-019-00436-x

Cited by 6 publications

(2 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The overall workload in the RTLX tended to be higher in the RobExReha group with a mean score of 41.7 compared to the Reference Group (mean: 34.1) without reaching a significant difference neither in the overall score nor domain-wise. Those are slightly lower compared to global work load scores, where video gaming had a median RTLX score of 56.5 [ 38 ], and to a serious gaming intervention in patients with chronic regional pain syndrome (mean 50.9) [ 39 ]. This could reflect that the demand of the robotic gaming therapy could potentially be higher for some patients.…”

Section: Discussionmentioning

confidence: 99%

Robotic arm training in neurorehabilitation enhanced by augmented reality – a usability and feasibility study

de Crignis,

Ruhnau,

Hösl

et al. 2023

J NeuroEngineering Rehabil

View full text Add to dashboard Cite

Background Robotic therapy and serious gaming support motor learning in neurorehabilitation. Traditional monitor-based gaming outputs cannot adequately represent the third dimension, whereas virtual reality headsets lack the connection to the real world. The use of Augmented Reality (AR) techniques could potentially overcome these issues. The objective of this study was thus to evaluate the usability, feasibility and functionality of a novel arm rehabilitation device for neurorehabilitation (RobExReha system) based on a robotic arm (LBR iiwa, KUKA AG) and serious gaming using the AR headset HoloLens (Microsoft Inc.). Methods The RobExReha system was tested with eleven adult inpatients (mean age: 64.4 ± 11.2 years; diagnoses: 8 stroke, 2 spinal cord injury, 1 Guillain-Barré-Syndrome) who had paretic impairments in their upper limb. Five therapists administered and evaluated the system. Data was compared with a Reference Group (eleven inpatients; mean age: 64.3 ± 9.1 years; diagnoses: 10 stroke, 1 spinal cord injury) who trained with commercially available robotic therapy devices (ArmeoPower or ArmeoSpring, Hocoma AG). Patients used standardized questionnaires for evaluating usability and comfort (Quebec User Evaluation of Satisfaction with assistive technology [QUEST]), workload (Raw Task Load Index [RTLX]) and a questionnaire for rating visual perception of the gaming scenario. Therapists used the QUEST, the System Usability Scale and the short version of the User Experience Questionnaire. Results Therapy with the RobExReha system was safe and feasible for patients and therapists, with no serious adverse events being reported. Patients and therapists were generally satisfied with usability. The patients’ usability ratings were significantly higher in the Reference Group for two items of the QUEST: reliability and ease of use. Workload (RTLX) ratings did not differ significantly between the groups. Nearly all patients using the RobExReha system perceived the gaming scenario in AR as functioning adequately despite eight patients having impairments in stereoscopic vision. The therapists valued the system’s approach as interesting and inventive. Conclusions We demonstrated the clinical feasibility of combining a novel robotic upper limb robot with an AR-serious game in a neurorehabilitation setting. To ensure high usability in future applications, a reliable and easy-to-use system that can be used for task-oriented training should be implemented. Trial registration Ethical approval was obtained and the trial was registered at the German Clinical Trials Register (DRKS00022136).

show abstract

Section: Discussionmentioning

confidence: 99%

Robotic arm training in neurorehabilitation enhanced by augmented reality – a usability and feasibility study

de Crignis,

Ruhnau,

Hösl

et al. 2023

J NeuroEngineering Rehabil

View full text Add to dashboard Cite

show abstract

“…Over the past decade, numerous devices that included at-home physical rehabilitation using video game technology received 510(k) clearance. This began with Jintronix (Jintronix Inc.) [60][61][62] and went on to include the Recovr Rehabilitation System (Recovr, Inc.) [63], Vera (Reflexion Health, Inc.) [64], the Yugo System (BioGaming Ltd.), the Virtual Occupational Therapy Application (Barron Associates, Inc., marketed as SaeboVR by Saebo, Inc.) [65][66][67], Uincare Home (UINCARE Corp.) [68], and MindMotion Go (MindMaze SA) [69]. These devices are regulated as Class II devices in the United States.…”

Section: Requirements Analysismentioning

confidence: 99%

Using Medical Device Standards for Design and Risk Management of Immersive Virtual Reality for At-Home Therapy and Remote Patient Monitoring

Peter¹

2021

JMIR Biomed Eng

View full text Add to dashboard Cite

Numerous virtual reality (VR) systems have received regulatory clearance as therapeutic medical devices for in-clinic and at-home use. These systems enable remote patient monitoring of clinician-prescribed rehabilitation exercises, although most of these systems are nonimmersive. With the expanding availability of affordable and easy-to-use head-mounted display (HMD)-based VR, there is growing interest in immersive VR therapies. However, HMD-based VR presents unique risks. Following standards for medical device development, the objective of this paper is to demonstrate a risk management process for a generic immersive VR system for remote patient monitoring of at-home therapy. Regulations, standards, and guidance documents applicable to therapeutic VR design are reviewed to provide necessary background. Generic requirements for an immersive VR system for home use and remote patient monitoring are identified using predicate analysis and specified for both patients and clinicians using user stories. To analyze risk, failure modes and effects analysis, adapted for medical device risk management, is performed on the generic user stories and a set of risk control measures is proposed. Many therapeutic applications of VR would be regulated as a medical device if they were to be commercially marketed. Understanding relevant standards for design and risk management early in the development process can help expedite the availability of innovative VR therapies that are safe and effective.

show abstract

Ergotherapie bei komplexem regionalem Schmerzsyndrom

Storz

Kraft

2021

Schmerz

View full text Add to dashboard Cite

Exergames für Patienten mit komplexem regionalem Schmerzsyndrom

Cited by 6 publications

References 23 publications

Robotic arm training in neurorehabilitation enhanced by augmented reality – a usability and feasibility study

Robotic arm training in neurorehabilitation enhanced by augmented reality – a usability and feasibility study

Using Medical Device Standards for Design and Risk Management of Immersive Virtual Reality for At-Home Therapy and Remote Patient Monitoring

Ergotherapie bei komplexem regionalem Schmerzsyndrom

Contact Info

Product

Resources

About